ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

HARP Harpoon Therapeutics Inc

23.01
0.00 (0.00%)
최종 업데이트: 09:00:00
15분 지연
기업명 주식 심볼 시장 주식 타입
Harpoon Therapeutics Inc HARP 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 23.01 09:00:00
개장가 저가 고가 종가 전일 종가
23.01
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
12/03/202406:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/03/202422:55EDGAR2Form POS AM - Post-Effective amendments for registration..
11/03/202422:46EDGAR2Form S-8 POS - Securities to be offered to employees in..
11/03/202421:47EDGAR2Form 8-K - Current report
09/03/202406:04EDGAR2Form 8-K - Current report
28/02/202421:37EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
28/02/202421:34EDGAR2Form 8-K - Current report
22/02/202422:32EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/02/202422:31EDGAR2Form 8-K - Current report
08/02/202421:00EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
07/02/202406:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
30/01/202406:52EDGAR2Form PREM14A - Preliminary proxy statements relating to..
30/01/202406:28EDGAR2Form 8-K - Current report
11/01/202405:07PRNUSKuehn Law Encourages AMAM, HARP, AXNX, and CPE Investors to..
09/01/202420:12IHMARKETNEWSWall Street Highlights: HPE and Juniper Networks in..
09/01/202407:20EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
09/01/202407:16EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/01/202422:04EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/01/202422:01EDGAR2Form 8-K - Current report
08/01/202421:30BWMerck to Acquire Harpoon Therapeutics, Further Diversifying..
06/01/202407:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/12/202321:30GLOBEHarpoon Therapeutics Strengthens Leadership Team
23/12/202306:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
20/12/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
19/12/202321:30GLOBEHarpoon Therapeutics Abstract for HPN328 Accepted for Rapid..
12/12/202310:15GLOBEHarpoon Therapeutics Presents HPN217 Phase 1 Clinical Data..
09/12/202306:08EDGAR2Form S-3 - Registration statement under Securities Act of..
29/11/202306:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202306:14EDGAR2Form 8-K - Current report
25/11/202304:06EDGAR2Form 8-K - Current report
25/11/202304:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/11/202306:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202306:11EDGAR2Form 8-K - Current report
10/11/202306:01GLOBEHarpoon Therapeutics Reports Third Quarter 2023 Financial..
04/11/202305:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02/11/202322:15GLOBEHarpoon Therapeutics Abstract for HPN217 Accepted for..
27/10/202306:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
23/10/202321:00EDGAR2Form 8-K - Current report
23/10/202320:17GLOBEHarpoon Therapeutics Announces Up to $150 Million Private..
22/10/202300:31GLOBEHarpoon Therapeutics Announces Updated Interim Tolerability..
17/10/202305:05GLOBEHarpoon Therapeutics to Host Webcast Reviewing HPN328..
10/10/202305:17GLOBEHarpoon Therapeutics to Present Interim Tolerability and..
03/10/202306:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/09/202316:00GLOBEHarpoon Therapeutics Presents HPN217 Interim Phase 1 Data at..
15/09/202320:15GLOBEHarpoon Therapeutics Announces First Patients with Small..
14/09/202306:12DJNHarpoon Shares Drop 7.3% as AbbVie Declines License Option
14/09/202305:55DJNHarpoon Therapeutics Says AbbVie Declines to Exercise..
14/09/202305:15EDGAR2Form 8-K - Current report
14/09/202305:05GLOBEHarpoon Therapeutics Provides an Update on the HPN217..
06/09/202320:30GLOBEHarpoon Therapeutics Abstract for HPN217 Accepted for Poster..

최근 히스토리

Delayed Upgrade Clock